What’s outside the quote?

Find the price behind the headline.

Ask for the cost now, the cost after any offer ends, and the cost of care around the medicine.

Get these costs in writing.

Ask your insurance plan about the exact use.

Medicare drug coverage can include these medicines for accepted uses besides weight loss, as of September 26, 2026.

A plan may still refuse to pay. It checks whether the medicine is on its covered list and whether your case meets its rules.

What is the temporary Medicare option?

A dated option, with limits

The Medicare GLP-1 Bridge, checked on September 26, 2026, offers certain weight medicines to eligible participants at a cost of $50 per month’s supply.

July 1, 2026, is the Bridge’s start date; its last day is December 31, 2027.

Part D is Medicare’s prescription drug coverage. The Bridge uses a separate system to check requests and pay pharmacies in 2026.

Ask your prescriber and pharmacy to check the Bridge process. The $50 offer is not the usual price through your drug plan.

The rules checked on September 26, 2026, set the minimum age at 18. Your coverage must be a Part D drug plan on its own, or a Medicare Advantage plan of a type that includes drug coverage and permits Bridge use.

Ask your plan to confirm that its type qualifies. Having Medicare alone does not settle this.

Your weight and health when you started GLP-1 treatment must meet one of the three groups below. BMI, short for body mass index, is a number based on your height and weight. Ask your clinician to work it out and check the diagnoses in your records.

  • BMI of 35 or higher

    This weight group does not require one of the extra health problems listed below.

  • BMI of 30 or higher, with a listed health problem

    One listed problem is heart failure with preserved pumping strength. The medical name is heart failure with preserved ejection fraction.

    Another is high blood pressure that stays above 140 on the top reading or 90 on the bottom reading. This must be despite treatment with two medicines for blood pressure.

    The third is long-term kidney disease graded stage 3a or higher. Ask your clinician to check the diagnosis, readings or kidney stage in your records.

  • BMI of 27 or higher, with a listed health problem

    One listed problem is pre-diabetes: blood sugar is raised, but diabetes has not yet developed. A past heart attack or a past stroke also meets this health rule.

    The other listed problem is disease in the arteries that causes arm or leg symptoms. This is called symptomatic peripheral artery disease.

The rules checked September 26, 2026, exclude people who have type 2 diabetes from the Bridge’s $50 offer. They ask their usual Part D plan about coverage instead. Payment still depends on the plan’s rules.

The Bridge also excludes people with moderate or severe obstructive sleep apnea, meaning blocked breathing during sleep. It excludes a specific fatty liver disease with inflammation and moderate or advanced scarring, called MASH, when there is no cirrhosis, the most severe scarring stage. Other fatty liver diagnoses do not automatically rule you out.

If the prescription is for reducing heart attack or stroke risk, the request goes to your usual Part D plan.

If your Part D plan paid for your GLP-1 medicine during 2026, the Bridge is closed to you for 2026. By the September 26, 2026 check, the rule about earlier payments for 2027 had still not been set.

Your clinician must send a prescription and get approval for the Bridge. The medicine must be part of ongoing care that includes a planned approach to food and physical activity.

Under the rules checked September 26, 2026, your spending limit for drugs covered by Part D is $2,100 for 2026; for 2027, it is $2,400. The Bridge’s $50 payments do not help you reach those limits. You pay them in addition to what you pay for Part D medicines.

The Bridge covers Wegovy shots and tablets, and Zepbound only in its KwikPen, a pen holding more than one dose. It also covers Foundayo (orforglipron) tablets. Zepbound single-dose pens and vials are excluded.

Ask the prescriber and pharmacy to confirm the exact product before expecting the $50 price.

Read Medicare’s patient explanationCheck the full eligibility and product rules

Check the terms of a savings card.

The September 26, 2026 check found that savings cards require commercial insurance for Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide).

These cards reduce the insured patient’s share of the bill; they exclude Medicare, Medicaid and military coverage.

Commercial insurance means an eligible workplace or private insurance plan.

A maker’s cash offer is different from a savings card. People with Medicare may be allowed to use the cash offer, even though they cannot use the card.

When you use a cash offer, you pay the full cash price yourself. Insurance pays none of that bill, and the payment does not help you reach your insurance plan’s spending limits.

Ask which kind of offer is being quoted, and whether it can be used with your coverage.

Keep the money question with the care question

Take the full quote to the visit.

Go to this desk